NCT06997354 Validation of a Parental Questionnaire for Screening Children for Neurovisual Disorders
| NCT ID | NCT06997354 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Université Catholique de Louvain |
| Condition | Children Suffering From Cortical Visual Impairment |
| Study Type | OBSERVATIONAL |
| Enrollment | 250 participants |
| Start Date | 2025-04-01 |
| Primary Completion | 2025-06-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 250 participants in total. It began in 2025-04-01 with a primary completion date of 2025-06-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Some children present visual difficulties linked not to damage to the eye, but to damage to the brain. This type of dysfunction of the visual cerebral pathways leads, for example, to difficulties in recognition, visuomotor coordination or visuo-spatial disorders. These highly specific disorders are known as "cortical visual impairment" (CVI). Despite their real impact on children's development, these disorders are still poorly diagnosed in the French-speaking world. As a result, follow-up and care for these children are poorly adapted. A better understanding of neurovisual disorders and the availability of validated tools in French are therefore essential. Indeed, it is currently considered that 3 to 4% of children aged four to six, i.e. around one child per kindergarten class, have a CVI following a neuro-logical lesion acquired in the perinatal period. Because of the lack of a valid tool in French, the aim of the present study is to provide the results of a validation study of a parental questionnaire for screening children with warning signs of CVI in French. This questionnaire will be offered online using the Qualtrics tool. In order to evaluate the relevance of this questionnaire, it will be proposed, on the one hand, to parents whose child (aged 3 to 12) does not present any particular developmental difficulties, and on the other hand, to parents whose child (aged 3 to 12) seems to present signs of neurovisual disorders. By comparing their answers, the investigators hope that certain questions will reveal elements typical of neurovisual disorders/CVI, thus demonstrating the relevance of this questionnaire in facilitating diagnosis.
Eligibility Criteria
Inclusion Criteria: * Parents of a child aged between 3 and 12 * Their mother tongue must be French, to ensure that they understand the questions asked in writing. Control group: \- Children of the parents surveyed who do not present any medical, school or family developmental particularities. Clinical group \- Children of the parents interviewed who present warning signs of CVI reported by a multidisciplinary team specialized in visual impairment. Exclusion Criteria: * no specific criteria (see inclusion criteria)
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06997354 clinical trial?
This trial is open to participants of all sexes, aged 3 Years or older, studying Children Suffering From Cortical Visual Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06997354 currently recruiting?
Yes, NCT06997354 is actively recruiting participants. Contact the research team at anne.bragard@uclouvain.be for enrollment information.
Where is the NCT06997354 trial being conducted?
This trial is being conducted at Louvain-la-Neuve, Belgium.
Who is sponsoring the NCT06997354 clinical trial?
NCT06997354 is sponsored by Université Catholique de Louvain. The trial plans to enroll 250 participants.